| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2143538 | Lung Cancer | 2008 | 8 Pages |
Abstract
The addition of CAI following chemotherapy does not provide clinical benefit or improvement in QOL over placebo in advanced NSCLC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Elizabeth A. Johnson, Randolph S. Marks, Sumithra J. Mandrekar, Shauna L. Hillman, Mark D. Hauge, Mitchel D. Bauman, Edward J. Wos, Dennis F. Moore, John W. Kugler, Harold E. Windschitl, David L. Graham, Albert M. Jr., Tom R. Fitch, Gamini S. Soori,